Nuvigil Side Effects Lawsuit Attorney
The latest Drug Safety newsletter of the Irish Medicines Board released on May 15th has warned people against taking recourse to wakefulness promoting drugs, such as Nuvigil and Provigil, to treat excessive sleepiness. It has advised doctors to check heart conditions of patients using electrocardiogram and monitor blood pressure and heart beat regularly before prescribing these drugs. The IMB has also urged caution on the part of users having a history of psychosis, depression or mania.
Though the pharmaceuticals major Cephalon claims that its drug Nuvigil is an effective means to improving conditions of people having sleep apnea, narcolepsy, and shift work sleep disorder, the Side Effects Lawsuit Attorney of the drug can lead to serious health problems. Wakefulness drugs may lead to one sleep problem while solving the other. It can cause lack of sleep that leads to a number of health complications, such as insomnia, fatigue, abnormal blood pressure, and lack of appetite. We need good sleep to help us recuperate and rejuvenate after long working hours. While lack of sleep induced by the drug can impact our efficiency and create mental problems, stimulant-like armodafinil in the drug is linked to Steven’s Johnson syndrome.
FDA Warning on Nuvigil
The FDA approved the marketing of Nuvigil in 2007 only after its manufacturer Cephalon agreed to carry label warnings on it. The federal regulator made a written request to the manufacturer two months before the market introduction of the drug to have mandatory and bold label warnings about skin rash and hypersensitivity Side Effects Lawsuit Attorney. It even asked the company to submit standard safety updates highlighted during clinical trials and mention them in introductory promotional materials. Such requirements are put forward only if the FDA is more concerned about the Side Effects Lawsuit Attorney of a drug. In October 2007, the FDA updated healthcare professionals about warnings related to prescription of Provigil, a lesser variant of Nuvigil.
In December 2010, the FDA rejected Cephalon’s request to allow Nuvigil pill to treat jet lag. Though there was no official word on the reason for not allowing the drug to treat jet lag, speculations were rife that the FDA had greater concerns on Side Effects Lawsuit Attorney of the drug. Similar circumstances had forced the pharmaceuticals major to abandon plans to market Nuvigil for schizophrenia treatment last June.